These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12831371)

  • 41. Effect of a new immunosuppressant, FTY720, on joint allografts.
    Watanabe H; Hamada Y; Toshima T; Nagasawa K; Sakano Y
    J Reconstr Microsurg; 1999 May; 15(4):295-8. PubMed ID: 10363553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An immunosuppressive regimen using FTY720 combined with cyclosporin in canine kidney transplantation.
    Suzuki S; Kakefuda T; Amemiya H; Chiba K; Hoshino Y; Kawaguchi T; Kataoka H; Rahman F
    Transpl Int; 1998; 11(2):95-101. PubMed ID: 9561675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FTY720: a most promising immunosuppressant modulating immune cell functions.
    Zhang Z; Schluesener HJ
    Mini Rev Med Chem; 2007 Aug; 7(8):845-50. PubMed ID: 17692046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
    Paugh SW; Payne SG; Barbour SE; Milstien S; Spiegel S
    FEBS Lett; 2003 Nov; 554(1-2):189-93. PubMed ID: 14596938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.
    Suzuki T; Jin MB; Shimamura T; Yamashita K; Taniguchi M; Nomura M; Yokota R; Fukai M; Magata S; Horiuchi H; Fujita M; Nagashima K; Furukawa H; Todo S
    Transpl Int; 2004 Nov; 17(10):574-84. PubMed ID: 15592714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis.
    Baumruker T; Billich A; Brinkmann V
    Expert Opin Investig Drugs; 2007 Mar; 16(3):283-9. PubMed ID: 17302523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
    Pinschewer DD; Ochsenbein AF; Odermatt B; Brinkmann V; Hengartner H; Zinkernagel RM
    J Immunol; 2000 Jun; 164(11):5761-70. PubMed ID: 10820254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolongation of concordant xenograft survival by treatment with FTY720.
    Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
    Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
    [No Abstract]   [Full Text] [Related]  

  • 49. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.
    Budde K; Schmouder RL; Brunkhorst R; Nashan B; Lücker PW; Mayer T; Choudhury S; Skerjanec A; Kraus G; Neumayer HH
    J Am Soc Nephrol; 2002 Apr; 13(4):1073-1083. PubMed ID: 11912269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overview of FTY720 clinical pharmacokinetics and pharmacology.
    Kovarik JM; Schmouder RL; Slade AJ
    Ther Drug Monit; 2004 Dec; 26(6):585-7. PubMed ID: 15570180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
    Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S
    Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.
    Mulgaonkar S; Tedesco H; Oppenheimer F; Walker R; Kunzendorf U; Russ G; Knoflach A; Patel Y; Ferguson R;
    Am J Transplant; 2006 Aug; 6(8):1848-57. PubMed ID: 16771816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
    Klatt J; Hartung HP; Hohlfeld R
    Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
    Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
    Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients.
    Budde K; L Schmouder R; Nashan B; Brunkhorst R; W Lücker P; Mayer T; Brookman L; Nedelman J; Skerjanec A; Böhler T; Neumayer HH
    Am J Transplant; 2003 Jul; 3(7):846-54. PubMed ID: 12814476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
    Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
    Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FTY720 prevents chronic rejection of rat heterotopic cardiac allografts.
    Chueh SC; Chen JR; Chen J; Lai MK
    Transplant Proc; 2001; 33(1-2):542-3. PubMed ID: 11266948
    [No Abstract]   [Full Text] [Related]  

  • 58. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
    Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
    Transplantation; 2004 Jun; 77(12):1826-33. PubMed ID: 15223899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rescuing acute rejection of rat cardiac allografts with FTY720.
    Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
    [No Abstract]   [Full Text] [Related]  

  • 60. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
    Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
    Transplantation; 2005 Jun; 79(11):1553-60. PubMed ID: 15940045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.